PUBLIC COMPANY
save$ACRSAclaris Therapeutics, Inc.
$ACRSWayne, PA, USupdated 2mo ago
community read0 votes
pipeline
3
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(3)
pipeline depth3 products
1Phase 12Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis
- phase2Study of ATI-2138 in Adult Participants With Moderate to Severe Atopic Dermatitis
- phase2ATI-450 vs Placebo in Participants With Moderate to Severe Hidradenitis Suppurativa (HS)
- phase2Study of ATI-450 vs Placebo in Patients With Moderate to Severe Psoriatic Arthritis
- phase2Study of ATI-1777 in Patients 12 to 65 Years Old With Mild to Severe Atopic Dermatitis
- phase2ATI-450 Plus Methotrexate (MTX) Versus Placebo Plus MTX in Participants With Moderate to Severe Active Rheumatoid Arthritis (RA)
- phase2Study of ATI-1777 in Adult Patients With Moderate or Severe Atopic Dermatitis
- phase2Study of ATI-450 in Patients With Cryopyrin-Associated Periodic Syndrome (CAPS)
Insider activity
source: SEC Form 4routine RSU / option mechanics (3)
- Mar 1, 26tax coverBalthaser Kevin · Chief Financial Officer677 sh
- Mar 1, 26option exerciseBalthaser Kevin · Chief Financial Officer2,375 sh
- Mar 1, 26option exerciseBalthaser Kevin · Chief Financial Officer2,375 sh
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 15m ago
Found something off?
comments(0)
5-min edit window · permanent after that